Omnicell (OMCL – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Stan Berenshteyn from Wells Fargo maintained a Hold rating on the stock and has ...
Omnicell , Inc. (NASDAQ:OMCL), a leading provider of medication management solutions in the healthcare technology sector, has ...
Hosted on MSN
Omnicell (NASDAQ:OMCL) Reports Upbeat Q2, Full-Year Outlook Slightly Exceeds Expectations
Healthcare tech company Omnicell (NASDAQ:OMCL) announced in Q2 CY2025, with sales up 5% year on year to $290.6 million. On top of that, next quarter’s revenue guidance ($295 million at the midpoint) ...
Omnicell, Inc. is a pharmacy management provider working towards the goal of an autonomous pharmacy. Q3 earnings looked weak on the surface with revenue and EBITDA down, but results by business show a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results